Combination of paeoniflorin and liquiritin alleviates neuropathic pain by lipid metabolism and calcium signaling coordination

Neuropathic pain (NP) affects 7%–10% of the general population and is still hard to cure. Here, we validated the therapeutic effect and demonstrated the mechanism of paeoniflorin and liquiritin combination (PL) on NP from the perspective of integrated lipidomics and transcriptomics for the first tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan-Yan, Feng, Li-Mei, Xu, Ding-Qiao, Yue, Shi-Jun, Fu, Rui-Jia, Zhang, Mei-Mei, Tang, Yu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489943/
https://www.ncbi.nlm.nih.gov/pubmed/36160378
http://dx.doi.org/10.3389/fphar.2022.944386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489943/
https://www.ncbi.nlm.nih.gov/pubmed/36160378
http://dx.doi.org/10.3389/fphar.2022.944386

Ejemplares similares